Nektar Therapeutics

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.21%159.650.7%$1260.61m
PFEPfizer Inc. 0.40%33.670.9%$1163.42m
BMYBristol-Myers Squibb Co. -0.19%61.521.0%$829.03m
MRKMerck & Co., Inc. 0.84%72.990.7%$826.12m
ABBVAbbVie, Inc. 0.35%108.791.9%$772.04m
LLYEli Lilly & Co. -0.05%206.371.1%$677.33m
AZNAstraZeneca Plc -0.50%47.851.2%$496.20m
GSKGlaxoSmithKline Plc 1.48%34.230.2%$282.32m
NVSNovartis AG 2.18%88.460.2%$176.03m
SNYSanofi 0.46%46.120.2%$167.21m
VTRSViatris, Inc. -3.45%14.210.0%$140.11m
VERUVeru, Inc. -1.77%14.160.0%$123.12m
CVACCureVac NV -3.67%92.660.0%$92.37m
NVONovo Nordisk A/S 0.21%72.790.1%$92.11m
KALVKalVista Pharmaceuticals, Inc. -2.96%32.440.4%$88.23m

Company Profile

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.